Cargando…

Intranasally Administered Antigen 85B Gene Vaccine in Non-Replicating Human Parainfluenza Type 2 Virus Vector Ameliorates Mouse Atopic Dermatitis

Atopic dermatitis (AD) is a refractory and recurrent inflammatory skin disease. Various factors including heredity, environmental agent, innate and acquired immunity, and skin barrier function participate in the pathogenesis of AD. T -helper (Th) 2-dominant immunological milieu has been suggested in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitagawa, Hiroshi, Kawano, Mitsuo, Yamanaka, Keiichi, Kakeda, Masato, Tsuda, Kenshiro, Inada, Hiroyasu, Yoneda, Misao, Sakaguchi, Tadashi, Nigi, Akina, Nishimura, Koumei, Komada, Hiroshi, Tsurudome, Masato, Yasutomi, Yasuhiro, Nosaka, Tetsuya, Mizutani, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701015/ https://www.ncbi.nlm.nih.gov/pubmed/23843958 http://dx.doi.org/10.1371/journal.pone.0066614

Ejemplares similares

Effects of Mycobacteria Major Secretion Protein, Ag85B, on Allergic Inflammation in the Lung
por: Tsujimura, Yusuke, et al.
Publicado: (2014)

Legume Lectins Inhibit Human Parainfluenza Virus Type 2 Infection by Interfering with the Entr
por: Uematsu, Jun, et al.
Publicado: (2012)

The Hemagglutinin-Neuraminidase (HN) Head Domain and the Fusion (F) Protein Stalk Domain of the Parainfluenza Viruses Affect the Specificity of the HN-F Interaction
por: Tsurudome, Masato, et al.
Publicado: (2018)

A versatile platform technology for recombinant vaccines using non-propagative human parainfluenza virus type 2 vector
por: Ohtsuka, Junpei, et al.
Publicado: (2019)

Calcineurin Inhibitors Suppress Cytokine Production from Memory T Cells and Differentiation of Naïve T Cells into Cytokine-Producing Mature T Cells
por: Tsuda, Kenshiro, et al.
Publicado: (2012)

Single systemic administration of Ag85B of mycobacteria DNA inhibits allergic airway inflammation in a mouse model of asthma
por: Karamatsu, Katsuo, et al.
Publicado: (2012)

Intratumoral Injection of Propionibacterium acnes Suppresses Malignant Melanoma by Enhancing Th1 Immune Responses
por: Tsuda, Kenshiro, et al.
Publicado: (2011)

Enhanced growth of influenza A virus by coinfection with human parainfluenza virus type 2
por: Goto, Hideo, et al.
Publicado: (2015)

Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations
por: Habe, Koji, et al.
Publicado: (2019)

The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis
por: Habe, Koji, et al.
Publicado: (2017)

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
por: Le Nouën, Cyril, et al.
Publicado: (2022)

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques
por: Nouën, Cyril Le, et al.
Publicado: (2022)

Dry pleural dissemination of malignancy diagnosed by aggressive thoracoscopy
por: Nigi, Akina, et al.
Publicado: (2021)

Primary melanoma in the bronchus
por: Nigi, Akina, et al.
Publicado: (2021)

A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters
por: Liu, Xueqiao, et al.
Publicado: (2021)

Report of a case of acinar cell carcinoma with its differential diagnosis on endoscopic ultrasound-guided fine-needle aspiration cytology
por: Yoneda, Misao, et al.
Publicado: (2014)

Immunological association of inducible bronchus-associated lymphoid tissue organogenesis in Ag85B-rHPIV2 vaccine-induced anti-tuberculosis mucosal immune responses in mice
por: Nagatake, Takahiro, et al.
Publicado: (2018)

Efficacy of a live intranasal vaccine against parainfluenza type 3 and bovine respiratory syncytial virus in young calves with maternally derived antibodies
por: Metcalfe, Lucy, et al.
Publicado: (2020)

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults
por: Scaggs Huang, Felicia, et al.
Publicado: (2020)

Persistent Release of IL-1s from Skin Is Associated with Systemic Cardio-Vascular Disease, Emaciation and Systemic Amyloidosis: The Potential of Anti-IL-1 Therapy for Systemic Inflammatory Diseases
por: Yamanaka, Keiichi, et al.
Publicado: (2014)

Rhabdomyolysis Associated with Parainfluenza Virus
por: Douvoyiannis, Miltiadis, et al.
Publicado: (2013)

Intranasal parainfluenza virus type 5 (PIV5)–vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study
por: Spearman, Paul, et al.
Publicado: (2023)

Significant intratumoral heterogeneity of human epidermal growth factor receptor 2 status in gastric cancer: A comparative study of immunohistochemistry, FISH, and dual‐color in situ hybridization
por: Kanayama, Kazuki, et al.
Publicado: (2016)

Viability of diffuse large B-cell lymphoma cells is regulated by kynurenine 3-monooxygenase activity
por: Morita, Nanaka, et al.
Publicado: (2021)

Increased 8‐Hydroxyguanine in DNA and Its Repair Activity in Hamster and Rat Lung after Intratracheal Instillation of Crocidolite Asbestos
por: Yamaguchi, Raizo, et al.
Publicado: (1999)

Characterization of Two Porcine Parainfluenza Virus 1 Isolates and Human Parainfluenza Virus 1 Infection in Weaned Nursery Pigs
por: Welch, Michael, et al.
Publicado: (2022)

Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge
por: Clark, Kimberly M., et al.
Publicado: (2011)

Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates
por: Liu, Xueqiao, et al.
Publicado: (2020)

Early Activation of the Innate Immunity and Specific Cellular Immune Pathways after Vaccination with a Live Intranasal Viral Vaccine and Challenge with Bovine Parainfluenza Type 3 Virus
por: Nuijten, Piet, et al.
Publicado: (2022)

A parainfluenza virus 5 (PIV5)-vectored intranasal vaccine for Lyme disease provides long-lasting protection against tick transmitted Borrelia burgdorferi in mice
por: Gingerich, Maria Cristina, et al.
Publicado: (2023)

Cytokines and Chemokines in Irritant Contact Dermatitis
por: Lee, Haur Yueh, et al.
Publicado: (2013)

Human Parainfluenza Type 4 Infections, Canada
por: Vachon, Marie-Louise, et al.
Publicado: (2006)

Seasonality and clinical impact of human parainfluenza viruses
por: Maykowski, Philip, et al.
Publicado: (2018)

Haemophilus parainfluenzae urethritis through orogenital transmission
por: Saxena, Ajit, et al.
Publicado: (2018)

Influenza and Parainfluenza Associated Pediatric ICU Morbidity
por: Hon, Kam Lun, et al.
Publicado: (2010)

Parainfluenza Bronchiolitis Mimicking Recurrent Lobar Pneumonia
por: Bhattar, Keshav, et al.
Publicado: (2022)

Epidemiology and Clinical Presentation of Parainfluenza Type 4 in Children: A 3-Year Comparative Study to Parainfluenza Types 1–3
por: Frost, Holly M., et al.
Publicado: (2014)

Evaluating a Parainfluenza Virus 5-Based Vaccine in a Host with Pre-Existing Immunity against Parainfluenza Virus 5
por: Chen, Zhenhai, et al.
Publicado: (2012)

T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1
por: Harris, Katherine M., et al.
Publicado: (2020)

Colonoscopy in Patients Aged 85 Years or Older: An Observational Study
por: Isohata, Noriyuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fne4f79aomim8uss9k8c3vteu2